Printer Friendly

NEW DIMENSIONS IN MEDICINE RENEGOTIATES DISTRIBUTION AGREEMENT

 NEW DIMENSIONS IN MEDICINE RENEGOTIATES DISTRIBUTION AGREEMENT
 MINNEAPOLIS, July 23 /PRNewswire/ -- New Dimensions in Medicine (NDM), a wholly owned subsidiary of MEI Diversified Inc. today announced that it has renegotiated a new five-year distribution agreement with Baxter Healthcare Corporation to distribute NDM's electrodes (including wire and cables) and electricalsurgical product lines. Baxter is the largest medical supply distributor to hospitals in the United States.
 NDM also announced today the signing of Redline Healthcare, a nationwide alternate care distributor, and approximately 20 other alternate care distributors, to provide NDM's ClearSite(R) wound dressing product line a concentrated network of distribution throughout the United States. The U.S. alternate care (nursing home) market is considered three times larger than the U.S. hospital market which ClearSite is currently being sold in. ClearSite is a clear hydrogel which has several unique gel properties, including the ability to absorb two to three times its weight in wound exudate while maintaining its integrity and clarity throughout the healing process. Also, the unique dressing does not leave a residue on the patient and eliminates eschar (dead tissue) from sticking during dressing changes which makes it ideal for burn applications.
 -0- 7/23/92
 /CONTACT: Robert P. King of New Dimensions in Medicine, 612-339-8853/ CO: New Dimensions in Medicine; MEI Diversified Inc.; Baxter
 Healthcare; Redline Healthcare ST: Minnesota IN: MTC SU:


DS -- MN005 -- 2346 07/23/92 09:47 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 23, 1992
Words:233
Previous Article:THE WEST COMPANY APPOINTS EUROPEAN DIVISION PRESIDENT
Next Article:BERGEN BRUNSWIG ANNOUNCES EXPIRATION OF WAITING PERIOD; SENDS LETTER TO DURR-FILLAUER REQUESTING INFORMATION
Topics:


Related Articles
NEW DIMENSIONS IN MEDICINE AND NIPPON SIGMAX OF JAPAN ENTER INTO DISTRIBUTION AGREEMENT
NEW DIMENSIONS IN MEDICINE ENTERS INTO DISTRIBUTION AGREEMENT FOR CLEARSITE(R)
NEW DIMENSIONS IN MEDICINE ANNOUNCES DISTRIBUTION AGREEMENT FOR CLEARSITE
MEI DIVERSIFIED CONTINUES PROGRESS IN BUSINESS SEGMENTS
CONMED CORPORATION WILL ACQUIRE NEW DIMENSIONS IN MEDICINE, INC.
MICRO BIO-MEDICS, INC. SIGNS AN ESTIMATED $100 MILLION AGREEMENT WITH ST. LUKE'S-ROOSEVELT HOSPITAL CENTER IN MANHATTAN.
ORTHOFIX SUBSIDIARY SUCCESSFULLY SETTLES U.S. FOOTPUMP ACTION WITH NDM
MICRO BIO-MEDICS INC. SIGNS THREE-YEAR AGREEMENT; INITIAL SERVICE TO PROVIDE SALES OF $5 MILLION PER YEAR FOR THREE YEARS
Cambridge Laboratories Announces Approval of Tetrabenazine in Spain.
Cambridge Laboratories Announces Approval of Tetrabenazine in Spain.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters